STOCK MARKET BSE NSE

Sebi removes curbs on Brady & Morris, Gujarat Themis Biosyn

Securities and Exchange Board of India noted that the sale of 7.11 per cent stake by the firm in the open market \"is not a prescribed mode of compliance\" and that the firm had not sought the regulator\'s permission for open market sale.

Published: 05th November 2013 06:46 PM  |   Last Updated: 05th November 2013 06:46 PM   |  A+A-

By PTI

Market regulator Sebi today revoked the restrictions it had imposed on Gujarat Themis Biosyn and

Brady & Morris Engineering Company as well as their directors and promoters for not meeting the minimum public shareholding norms.

Sebi has revoked the curbs on Brady & Morris and its promoters and directors but has referred the case for adjudication proceedings "to levy suitable monetary penalty" as the firm did not adopt the methods available for complying with the minimum 25 per cent public holding requirements prescribed by the regulator.

Brady and Morrison had submitted that owing to market conditions, among other, it was not favourable for the company to come out either with a bonus issue or a rights issue. The firm had thereby sold 7.11 per cent of its stake in open market to Transparent Agro and others. After this, its promoter holding was reduced to 73.75 per cent.

Securities and Exchange Board of India (Sebi) noted that the sale of 7.11 per cent stake by the firm in the open market "is not a prescribed mode of compliance" and that the firm had not sought the regulator's permission for open market sale.

Over 100 companies, including Gujarat Themis Biosyn and Brady & Morris Engineering Company, had failed to achieve 25 per cent public holding by June 3 and were imposed with various curbs by the market regulator on June 4.

In its order against Gujarat Themis Biosyn, Sebi said it is vacating the directions in the interim order dated June 4, 2013 against the firm, its directors, and promoters with immediate effect on condition that it achieves the minimum public holding by March 31, 2014.

Sebi said that the curbs "shall immediately be revived(without the need for passing of a separate order) against the said company, its directors, promoters and the promoter group "if the company fails to meet norms by end of March .

The March 31 deadline is based upon an order of the Board for Industrial and Financial Reconstruction (BIFR). BIFR found Gujarat Themis Biosyn to be a sick company and had given it a period of 3 years to meet the minimum public holding.

In its June 4 order, Sebi had frozen the voting rights and corporate benefits of promoters/directors of non-compliant firms and barred them from holding any new position on boards of listed firms, among others.

Further, the regulator had warned the firms of further actions including levy of monetary penalties, initiation of criminal proceedings, restricting the trading activities of related stocks and other possible directions.



Full coverage State Elections 2013
Specials on: Narendra Modi | Rahul Gandhi | Sachin Tendulkar | World Chess Championship | VoXpress | Indian GP


Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

IPL_2020
flipboard facebook twitter whatsapp